Clinical Trial Update: Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating everolimus in thymoma and thymic carcinoma patients previously treated with chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Armando Santoro, MD | Conditions: Thymoma and Thymic Carcinoma | Phase 2 | Status: COMPLETED